Table 1.
Patient characteristics at baseline
| Characteristics | Value |
|---|---|
| Age, years | 59.4 ± 12.3 |
| Height, cm | 162.6 ± 9.6 |
| Duration of diabetes, months | 115.0 ± 88.8 |
| Men | 119 (58.3) |
| Macrovascular complications of diabetes | 36 (17.7) |
| Arteriosclerosis obliterans | 8 (3.9) |
| Coronary heart disease | 19 (9.3) |
| Stroke | 15 (7.3) |
| Diabetic microangiopathy | 106 (52.0) |
| Diabetic retinopathy | 49 (24.0) |
| Diabetic neuropathy | 47 (23.0) |
| Diabetic nephropathy | 83 (40.6) |
| Sulfonylurea before using GLP-1 | 123 (60.3) |
n = 204 except for height (n = 203) and duration of diabetes (n = 197) because of missing data. Data are shown as the mean ± SD or the number of patients (%)